Velocity Clinical Research is now a Society for Clinical Research Sites (SCRS) Global Impact Partnership (GIP). Paul Evans, PhD, President and CEO of Velocity, said the company is excited to leverage this partnership to further improve clinical research, both within Velocity and industry-wide. “The SCRS community can play an integral role in the way sites shape and share best practices — through advocating on our behalf, connecting us with other sites, Sponsors, and CROs, and providing one another with mentorship and educational opportunities. With this enhanced partnership, we look forward to sharing our expertise with SCRS and other GIP members on a greater scale.”=
Read the full press release at myscrs.org >
You can also hear Andrew Kimball, Executive Vice President of Strategic Commercial Relationships, discuss Velocity’s GIP membership in this SCRS Talks podcast >
